Skip to main content
AIM ImmunoTech Inc. (AIM)
NYSEAMERICAN: AIM · Real-Time Price · USD
0.520
+0.004 (0.85%)
At close: Apr 28, 2026, 4:00 PM EDT
0.520
0.00 (0.00%)
After-hours: Apr 28, 2026, 4:00 PM EDT

AIM ImmunoTech Revenue

In the year 2025, AIM ImmunoTech had annual revenue of $88.00K, down -48.24%. AIM ImmunoTech had revenue of $21.00K in the quarter ending December 31, 2025, a decrease of -53.33%.

Revenue (ttm)
$88.00K
Revenue Growth
-48.24%
P/S Ratio
47.74
Revenue / Employee
$4,190
Employees
21
Market Cap
4.24M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202588.00K-82.00K-48.24%
Dec 31, 2024170.00K-32.00K-15.84%
Dec 31, 2023202.00K61.00K43.26%
Dec 31, 2022141.00K6.00K4.44%
Dec 31, 2021135.00K-28.00K-17.18%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Jaguar Health 11.51M
60 Degrees Pharmaceuticals 1.41M
SciSparc 1.31M
VivoSim Labs 142.00K
Azitra 7.50K
Pulmatrix 3.00K
Soligenix 2.34K
Revenue Rankings

AIM News

More News